| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47781-951-30 | 47781-951 | HUMAN PRESCRIPTION DRUG | sertraline hydrochloride | sertraline hydrochloride | CAPSULE | ORAL | 20250922 | N/A | NDA AUTHORIZED GENERIC | NDA215133 | Alvogen, Inc. | SERTRALINE HYDROCHLORIDE | 150 mg/1 | 30 CAPSULE in 1 BOTTLE (47781-951-30) |
| 52427-664-30 | 52427-664 | HUMAN PRESCRIPTION DRUG | sertraline HCl | sertraline hydrochloride | CAPSULE | ORAL | 20211101 | N/A | NDA | NDA215133 | Almatica Pharma LLC | SERTRALINE HYDROCHLORIDE | 150 mg/1 | 30 CAPSULE in 1 BOTTLE (52427-664-30) |
| 52427-672-30 | 52427-672 | HUMAN PRESCRIPTION DRUG | sertraline HCl | sertraline hydrochloride | CAPSULE | ORAL | 20211101 | N/A | NDA | NDA215133 | Almatica Pharma LLC | SERTRALINE HYDROCHLORIDE | 200 mg/1 | 30 CAPSULE in 1 BOTTLE (52427-672-30) |
| 47781-962-30 | 47781-962 | HUMAN PRESCRIPTION DRUG | sertraline hydrochloride | sertraline hydrochloride | CAPSULE | ORAL | 20250922 | N/A | NDA AUTHORIZED GENERIC | NDA215133 | Alvogen, Inc. | SERTRALINE HYDROCHLORIDE | 200 mg/1 | 30 CAPSULE in 1 BOTTLE (47781-962-30) |